UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Yuhan licenses out gastrointestinal treatment to US partner
Yuhan Corp. said that it has licensed out YH12852, a gastrointestinal motil...
by Lee Han-soo
|
2020-08-20 16:58
라인
Regulator OKs P2 trial of Covid-19 plasma therapy
GC said that the Ministry of Food and Drug Safety has approved the phase 2 ...
by Lee Han-soo
|
2020-08-20 14:55
라인
KAIST develops model predicting number of imported Covid-19 cases
A research team at Korea Advanced Institute of Science and Technology (KAIS...
by Lee Han-soo
|
2020-08-19 16:13
라인
Bridge Bio shares plummet on possible cancellation of ₩1.5-trillion deal
Bridge Biotherapeutics shares tanked on Wednesday, as the company did not r...
by Lee Han-soo
|
2020-08-19 13:07
라인
Korea, Belgium researchers find new mechanism in treating colon cancer
Researchers at Samsung Medical Center and Katholieke Universiteit Leuven in...
by Lee Han-soo
|
2020-08-18 17:20
라인
LG Chem licenses in NASH treatment candidate from China
LG Chem said that it has licensed in TT-01025, a non-alcoholic steatohepati...
by Lee Han-soo
|
2020-08-18 15:18
라인
Medytox shares resurge as court allows sales resumption of Meditoxin
Medytox's shares hit its upper limits on Tuesday, as a local court acce...
by Lee Han-soo
|
2020-08-18 15:18
라인
GC Labcell confirms efficacy of NK cell therapy in treating Covid-19
GC Labcell said that it has confirmed the efficacy of its natural killer (N...
by Lee Han-soo
|
2020-08-18 15:10
라인
[From the scene] Doctors took to streets to protest increase of medical students
Doctors and medical students took off their medical gowns to protest the so...
by Lee Han-soo
|
2020-08-14 17:54
라인
SK Bioscience inks CDMO deal with Novavax for Covid-19 vaccine
SK Bioscience, a subsidiary of SK Chemical, has signed a CDMO (contract dev...
by Lee Han-soo
|
2020-08-14 15:36
라인
Celltrion to start P1 trial of Prolia biosimilar
Celltrion said that it would start phase 1 clinical trial of CT-P41, a Prol...
by Lee Han-soo
|
2020-08-14 15:32
라인
Covid-19 makes Vivozon halt P3 trial of nonnarcotic analgesics in US
said that it has halted its phase 3b clinical trials for using opiranserin,...
by Lee Han-soo
|
2020-08-13 17:27
라인
KASL holds world’s 1st int’l conference on liver online
“Liver Week 2020,” the first online international conference on the liver, ...
by Lee Han-soo
|
2020-08-13 16:34
라인
Celltrion Healthcare posts record-breaking Q2 profit
Celltrion Healthcare said Thursday that it recorded sales of 420.3 billion ...
by Lee Han-soo
|
2020-08-13 16:34
라인
Severance finds biomarker for predicting organ damage in ANCA-related vasculitis patients
Severance Hospital said its researchers have discovered a biomarker that ca...
by Lee Han-soo
|
2020-08-13 11:13
라인
Takeda expects more effective IBD treatment with Kynteles' expanded reimbursement
Takeda Korea is strengthening its position in the domestic inflammatory bow...
by Lee Han-soo
|
2020-08-12 17:45
라인
Celltrion launches 2 Covid-19 diagnostic kits in US
Celltrion said that it has launched two diagnostic kits of Covid-19 -- Samp...
by Lee Han-soo
|
2020-08-12 14:49
라인
Roche’s Tecentriq-Avastin combo wins nod to treat hepatocellular carcinoma
Roche has become the first company in Korea to win the regulator’s nod to u...
by Lee Han-soo
|
2020-08-12 14:35
라인
Petitioner demands insurance benefit for breast cancer drug Kadcyla
A woman has requested that the government grant reimbursement for using Kad...
by Kim Yun-mi
|
2020-08-11 17:49
라인
Daewoong to conduct P1 trial of Covid-19 treatment in India
Daewoong Pharmaceutical said that the Indian health regulators have approve...
by Lee Han-soo
|
2020-08-11 17:48
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top